- Home
- TDF vs LFCR Comparison
TDF vs LFCR Comparison
Compare TDF & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDF
- LFCR
- Stock Information
- Founded
- TDF 1994
- LFCR 1986
- Country
- TDF Singapore
- LFCR United States
- Employees
- TDF N/A
- LFCR N/A
- Industry
- TDF Finance/Investors Services
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- TDF Finance
- LFCR Health Care
- Exchange
- TDF Nasdaq
- LFCR Nasdaq
- Market Cap
- TDF 244.7M
- LFCR 288.0M
- IPO Year
- TDF N/A
- LFCR N/A
- Fundamental
- Price
- TDF $11.42
- LFCR $6.49
- Analyst Decision
- TDF
- LFCR Buy
- Analyst Count
- TDF 0
- LFCR 4
- Target Price
- TDF N/A
- LFCR $8.00
- AVG Volume (30 Days)
- TDF 79.2K
- LFCR 224.6K
- Earning Date
- TDF 01-01-0001
- LFCR 10-03-2025
- Dividend Yield
- TDF N/A
- LFCR N/A
- EPS Growth
- TDF N/A
- LFCR N/A
- EPS
- TDF N/A
- LFCR N/A
- Revenue
- TDF N/A
- LFCR $128,867,000.00
- Revenue This Year
- TDF N/A
- LFCR $4.71
- Revenue Next Year
- TDF N/A
- LFCR $10.98
- P/E Ratio
- TDF N/A
- LFCR N/A
- Revenue Growth
- TDF N/A
- LFCR 0.47
- 52 Week Low
- TDF $7.15
- LFCR $4.59
- 52 Week High
- TDF $10.62
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- TDF 48.82
- LFCR 37.77
- Support Level
- TDF $11.25
- LFCR $6.33
- Resistance Level
- TDF $11.68
- LFCR $6.82
- Average True Range (ATR)
- TDF 0.30
- LFCR 0.33
- MACD
- TDF -0.07
- LFCR -0.04
- Stochastic Oscillator
- TDF 38.15
- LFCR 13.52
About TDF Templeton Dragon Fund Inc.
Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invests in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.